SMART™ in Managed Care
As the health benefits industry moves increasing toward consumer-focused products and processes, Managed Care Organizations (MCOs) will be able to offer their members Xhale's SMART drugs to better manage their health.
Xhale's SMART drugs can reduce healthcare costs by empowering the MCO members through effective medication reminder/reward systems while empowering the organization through creation of patient adherence records. A definitive record of patient adherence will allow the physician to provide better care and make more informed decisions, and it will allow the MCO to integrate the SMART system into reward programs for patients who comply with their medication regimen.
- MCOs can provide SMART versions of drugs for large subpopulations of patients such as diabetes management and hypertension, tying definitive reporting on patient adherence to positive patient rewards.
- Physicians caring for patients who are who are unresponsive to a medication regimen can utilize a SMART version of a drug, measuring patient adherence before increasing dosage or adding another drug to the regimen.
- A mental health specialty practice group managing many outpatient clients on anti-psychotic medications can utilize a SMART version of the medication to monitor outpatient compliance, and to receive a warning notification if a patient becomes non-compliant.